CD34 and stroke disorder: Kadam et al. used intravenous injection of CD34+-enriched hUCBs to treat CI mice; the experimental results showed that neurogenic niche proliferation and glial brain responses to CD34+-enriched hUCBs after neonatal stroke might involve interactions with the spleen and were sex-dependent [197].